Insights from 15 years of collaborative microbiome research with Indigenous peoples in the Peruvian Amazon
Peer-Reviewed Publication
Updates every hour. Last Updated: 25-Jan-2026 20:11 ET (26-Jan-2026 01:11 GMT/UTC)
Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical trial of a novel vaccine designed to protect against both typhoid fever and invasive non-typhoidal Salmonella--two major causes of illness and death among children in sub-Saharan Africa.